Skip to content

Opening book details…

About this Medicine article

Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP) by Fensterer, H.; Schade-Brittinger, C.; Muller, H. - H.; Tebbe, S.; Fass, J.; Lindig, U.; Settmacher, U.; Schmidt, W. E.; Marten, A.; Ebert, M. P.; Kornmann, M.; Hofheinz, R.; Endlicher, E.; Brendel, C.; Barth, P. J.; Bartsch, D. K.; Michl, P.; Gress, T. M. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Fensterer, H.; Schade-Brittinger, C.; Muller, H. - H.; Tebbe, S.; Fass, J.; Lindig, U.; Settmacher, U.; Schmidt, W. E.; Marten, A.; Ebert, M. P.; Kornmann, M.; Hofheinz, R.; Endlicher, E.; Brendel, C.; Barth, P. J.; Bartsch, D. K.; Michl, P.; Gress, T. M.
Publisher
Oxford University Press; Elsevier BV (ISSN 0923-7534)
Published
2013
Field
Medicine (Health Sciences)

More by Fensterer, H.; Schade-Brittinger, C.; Muller, H. - H.; Tebbe, S.; Fass, J.; Lindig, U.; Settmacher, U.; Schmidt, W. E.; Marten, A.; Ebert, M. P.; Kornmann, M.; Hofheinz, R.; Endlicher, E.; Brendel, C.; Barth, P. J.; Bartsch, D. K.; Michl, P.; Gress, T. M.

Browse all works by Fensterer, H.; Schade-Brittinger, C.; Muller, H. - H.; Tebbe, S.; Fass, J.; Lindig, U.; Settmacher, U.; Schmidt, W. E.; Marten, A.; Ebert, M. P.; Kornmann, M.; Hofheinz, R.; Endlicher, E.; Brendel, C.; Barth, P. J.; Bartsch, D. K.; Michl, P.; Gress, T. M.